Christopher Carey

All of a sudden, renewed optimism about the government stimulus package and a handful of data points suggesting the spread of COVID-19 may be slowing has the S&P 500 up 10.3% since April 1. Unfortunately, the economy and the market are not out of the woods just yet. It may be years before some...

Shares of cannabis company Canopy Growth Corp (NYSE: CGC) (TSE: WEED) soared on Friday in New York and Toronto after the company reported a big third-quarter revenue and profit improvement. Two analysts maintained Buy ratings on the stock — and said the beat could help the sector as a...

A rough few months for Canopy Growth Corp (NYSE: CGC) investors got even worse on Friday when the stock was hit by a major Wall Street downgrade.  The Analyst Christopher Carey downgraded Canopy Growth from Buy to Neutral and cut the price target from $46 to $27. The Thesis Carey said he is...

Canadian cannabis company Aurora Cannabis Inc (NYSE: ACB) reported fourth-quarter results Wednesday that fell short of the company's own expectations and received a mixed review from two Street analysts. The Analysts Canaccord Genuity analyst Matt Bottomley maintained a...

Tobacco stocks were resilient on Wednesday after a series of negative headlines about the potential dangers of vaping and indications from President Donald Trump that a regulatory crackdown may be on the horizon. Vaping Crackdown On Wednesday morning, U.S. health secretary Alex Azar told reporters...

Cronos Group Inc (NASDAQ: CRON) on Friday announced a $300 million buyout of U.S. CBD company Redwood Holdings, owner of CBD brand Lord Jones. Cronos shares traded lower by 5% in a weak market on Monday, but Bank of America analyst Christopher Carey said the buyout is a shrewd move by Cronos and...

Cannabis producer company CannTrust Holdings Inc (NYSE: CTST) said Monday that it accepts a Health Canada non-compliance finding; this "sharp turn of events" prompted Bank of America Merrill Lynch to double downgrade the stock. The Analyst Christopher Carey downgraded CannTrust...

Canopy Growth Corp (NYSE: CGC) has parted ways with founder and co-CEO Bruce Linton and this marks an "end of an era," according to Bank of America. The Analyst Bank of America's Christopher Carey maintains a Buy rating on Canopy Growth with a $53 price target. Need more cannabis...

Canada's Canopy Growth Corp (NYSE: CGC) locked down its potential first-mover advantage in a wide-open U.S. cannabis market during a special shareholders meeting. On Wednesday, 99% of Canopy investors voted to approve the company’s conditional acquisition of U.S. cannabis dispenser...

Canadian cannabis company CannTrust Holdings Inc (NYSE: CTST) announced an expansion Wednesday to the U.S. — and in Bank of America Merrill Lynch's view, the company's international ambitions are "underappreciated" by investors. The Analyst Christopher Carey...

Consumer packaged goods cannabis company Hexo Corp (NYSE: HEXO) reported Wednesday evening fiscal third-quarter results, which one analyst described as "OK" as the company continues to build out towards an inflection point. The Analyst Bank of America's Christopher Carey maintains a...

Canopy Growth Corp (NYSE: CGC) recently announced a deal to acquire U.S. cannabis company Acreage Holdings Inc (OTC: ACRGF) that is contingent on U.S. federal legalization of marijuana. On Friday, one analyst said Acreage will be a key part of Canopy’s long-term U.S. strategy. The Analyst...

Cannabis stocks have been hot in 2019, but Cronos Group Inc (NASDAQ: CRON) shares have lagged the past three months. One Wall Street analyst says expansion opportunities into the U.S. market will soon send Cronos shares to new highs. The Analyst Bank of America analyst Christopher Carey upgraded...

Scotts Miracle-Gro Co (NYSE: SMG) shares cooled off Thursday after a 6-percent jump Wednesday following a stellar second-quarter print. Notwithstanding the results, fueled by strong Roundup and cannabis supplies sales, Bank of America Merrill Lynch turned bearish on the stock. The Analyst...